Skip to main content

Anthony (Tony) Hickey directs UNC Catalyst for Rare Disease, and is an RTI distinguished fellow in and program director for inhaled therapeutics, and is Professor Emeretis in the Division of Molecular Pharmaceutics at the UNC Eshelman School of Pharmacy. He is an expert in pharmaceutical formulations of antivirals and an expert in aerosol therapeutics.

Keywords: formulations, drug delivery, antiviral drug development
Researchers: Anthony Hickey

Alexander (Sasha) Kabanov is the Director at the UNC Center for Nanotechnology in Drug Delivery and the Mescal Swain Ferguson Distinguished Professor. His team is focusing on delivery of anti-CoV drugs and therapeutic agents to the respiratory track. Significant effort right now is focused on aerosolized delivery of insoluble active compounds, and is part of self-assembled Cross-disciplinary Consortium with Tony Hickey, Angela Kashuba, and Alex Tropsha, as well as experts in Schools of Public Health and Medicine.

Keywords: inhalational drug delivery, drug delivery
Researchers: Anthony Hickey, Angela Kashuba, Alexander Kabanov, Alex Tropsha

Juliane Nguyen, Associate Professor in the Eshelman School of Pharmacy’s Division of Pharmacoengineering and Molecular Pharmaceutics, is developing new formulations and biomaterials to create new therapeutics for the treatment of COVID-19.

Keywords: therapeutics
Researchers: Juliane Nguyen